Literature DB >> 1963425

Mechanisms of resistance to the 4-quinolone antibacterial agents.

G C Crumplin1.   

Abstract

Because of the close structural relationship of the fluorinated 4-quinolones to the parent compound nalidixic acid the mechanism of resistance is often perceived to be the same. However, it is clear that whilst the mechanism of resistance to fluorinated 4-quinolones is essentially the same, strains that are selected as resistant to nalidixic acid generally retain sensitivity to the newer agents. A number of mutations in the chromosome of Escherichia coli have been identified and these are described. These mutations affect the interaction of quinolones with their presumed targets (DNA gyrases) and the transport of quinolones through the cell membrane. A small number of other mutations giving rise to low-level resistance to nalidixic acid, which affect neither gyrase nor membrane function, are also recognized. Despite the recognition of these mutations, the practical application of this information is hampered by lack of knowledge of the normal uptake mechanisms, the processes involved in selection and maintenance of resistance, the relationship of resistance to pathogenicity and the frequency of occurrence of these mutations.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1963425     DOI: 10.1093/jac/26.suppl_f.131

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  7 in total

1.  Emergence and infectious complications of ciprofloxacin-resistant Escherichia coli in haematological cancer patients.

Authors:  M G van Kraaij; A W Dekker; E Peters; A Fluit; L F Verdonck; M Rozenberg-Arska
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1998-08       Impact factor: 3.267

2.  In vitro activity of Bay y 3118, a new quinolone.

Authors:  R J Fass
Journal:  Antimicrob Agents Chemother       Date:  1993-11       Impact factor: 5.191

3.  A novel, double mutation in DNA gyrase A of Escherichia coli conferring resistance to quinolone antibiotics.

Authors:  Q C Truong; J C Nguyen Van; D Shlaes; L Gutmann; N J Moreau
Journal:  Antimicrob Agents Chemother       Date:  1997-01       Impact factor: 5.191

4.  Novel gyrA point mutation in a strain of Escherichia coli resistant to fluoroquinolones but not to nalidixic acid.

Authors:  E Cambau; F Bordon; E Collatz; L Gutmann
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

5.  Antimicrobial susceptibilities of Campylobacter jejuni and Campylobacter coli isolated in Sweden: a 10-year follow-up report.

Authors:  E Sjögren; B Kaijser; M Werner
Journal:  Antimicrob Agents Chemother       Date:  1992-12       Impact factor: 5.191

6.  Development and validation of a diagnostic DNA microarray to detect quinolone-resistant Escherichia coli among clinical isolates.

Authors:  Xiaolei Yu; Milorad Susa; Cornelius Knabbe; Rolf D Schmid; Till T Bachmann
Journal:  J Clin Microbiol       Date:  2004-09       Impact factor: 5.948

7.  Antimicrobial genes from Allium sativum and Pinellia ternata revealed by a Bacillus subtilis expression system.

Authors:  Xi Kong; Mei Yang; Hafiz Muhammad Khalid Abbas; Jia Wu; Mengge Li; Wubei Dong
Journal:  Sci Rep       Date:  2018-09-28       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.